London Health Sciences Centre
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1875-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.lhsc.on.ca
Novel Fecal Microbiota Pill Enters Clinical Trial for Advanced Pancreatic Cancer Treatment
Canadian researchers launch Phase 1 trial of LND101, an oral fecal transplant therapy, targeting pancreatic cancer's dismal 10% five-year survival rate.